Collegium Pharmaceutical Statistics
Total Valuation
COLL has a market cap or net worth of $844.82 million. The enterprise value is $1.93 billion.
| Market Cap | 844.82M |
| Enterprise Value | 1.93B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COLL has 32.56 million shares outstanding. The number of shares has decreased by -9.08% in one year.
| Current Share Class | 32.56M |
| Shares Outstanding | 32.56M |
| Shares Change (YoY) | -9.08% |
| Shares Change (QoQ) | -18.98% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 119.27% |
| Float | 30.57M |
Valuation Ratios
The trailing PE ratio is 18.43 and the forward PE ratio is 3.64.
| PE Ratio | 18.43 |
| Forward PE | 3.64 |
| PS Ratio | 1.05 |
| Forward PS | 1.07 |
| PB Ratio | 2.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.58 |
| P/OCF Ratio | 2.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.76, with an EV/FCF ratio of 5.89.
| EV / Earnings | 40.37 |
| EV / Sales | 2.39 |
| EV / EBITDA | 5.76 |
| EV / EBIT | 12.29 |
| EV / FCF | 5.89 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 3.90.
| Current Ratio | 1.03 |
| Quick Ratio | 0.70 |
| Debt / Equity | 3.90 |
| Debt / EBITDA | 3.63 |
| Debt / FCF | 3.71 |
| Interest Coverage | 2.06 |
Financial Efficiency
Return on equity (ROE) is 17.61% and return on invested capital (ROIC) is 9.54%.
| Return on Equity (ROE) | 17.61% |
| Return on Assets (ROA) | 5.75% |
| Return on Invested Capital (ROIC) | 9.54% |
| Return on Capital Employed (ROCE) | 10.18% |
| Weighted Average Cost of Capital (WACC) | 5.75% |
| Revenue Per Employee | $1.91M |
| Profits Per Employee | $113,274 |
| Employee Count | 423 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.13 |
Taxes
In the past 12 months, COLL has paid $29.77 million in taxes.
| Income Tax | 29.77M |
| Effective Tax Rate | 38.32% |
Stock Price Statistics
The stock price has decreased by -27.64% in the last 52 weeks. The beta is 0.76, so COLL's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -27.64% |
| 50-Day Moving Average | 34.32 |
| 200-Day Moving Average | 39.19 |
| Relative Strength Index (RSI) | 21.57 |
| Average Volume (20 Days) | 516,352 |
Short Selling Information
The latest short interest is 5.23 million, so 16.08% of the outstanding shares have been sold short.
| Short Interest | 5.23M |
| Short Previous Month | 5.47M |
| Short % of Shares Out | 16.08% |
| Short % of Float | 17.12% |
| Short Ratio (days to cover) | 10.75 |
Income Statement
In the last 12 months, COLL had revenue of $808.21 million and earned $47.92 million in profits. Earnings per share was $1.41.
| Revenue | 808.21M |
| Gross Profit | 722.93M |
| Operating Income | 171.65M |
| Pretax Income | 77.68M |
| Net Income | 47.92M |
| EBITDA | 335.57M |
| EBIT | 157.44M |
| Earnings Per Share (EPS) | $1.41 |
Balance Sheet
The company has $129.47 million in cash and $1.22 billion in debt, with a net cash position of -$1.09 billion or -$33.43 per share.
| Cash & Cash Equivalents | 129.47M |
| Total Debt | 1.22B |
| Net Cash | -1.09B |
| Net Cash Per Share | -$33.43 |
| Equity (Book Value) | 311.91M |
| Book Value Per Share | 9.60 |
| Working Capital | 18.15M |
Cash Flow
In the last 12 months, operating cash flow was $329.92 million and capital expenditures -$1.64 million, giving a free cash flow of $328.28 million.
| Operating Cash Flow | 329.92M |
| Capital Expenditures | -1.64M |
| Depreciation & Amortization | 233.60M |
| Net Borrowing | 246.91M |
| Free Cash Flow | 328.28M |
| FCF Per Share | $10.08 |
Margins
Gross margin is 89.45%, with operating and profit margins of 21.24% and 5.93%.
| Gross Margin | 89.45% |
| Operating Margin | 21.24% |
| Pretax Margin | 9.61% |
| Profit Margin | 5.93% |
| EBITDA Margin | 41.52% |
| EBIT Margin | 19.48% |
| FCF Margin | 40.62% |
Dividends & Yields
COLL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 9.08% |
| Shareholder Yield | 9.08% |
| Earnings Yield | 5.67% |
| FCF Yield | 38.81% |
Analyst Forecast
The average price target for COLL is $51.20, which is 97.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $51.20 |
| Price Target Difference | 97.30% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 1.66% |
| EPS Growth Forecast (3Y) | -7.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
COLL has an Altman Z-Score of 0.99 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.99 |
| Piotroski F-Score | 5 |